
Elizabeth Bisaccia, PharmD, BCPPS
Advertisement
Articles by Elizabeth Bisaccia, PharmD, BCPPS

Advertisement
Latest Updated Articles
Updates in Clinical Data for FDA-approved Disease-modifying Therapies for Spinal Muscular AtrophyPublished: February 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
3
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
4
As Milestone Nears, an Early Investigator Reflects on Lessons of Imatinib
5



